Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Yimintang Pharmaceutical is a Chinese pharmaceutical company focused on the research, development, and large-scale production of Traditional Chinese Medicine (TCM) and modern chemical drugs. Based in the Jilin High-tech Industrial Development Zone, the company operates multiple GMP-certified production lines for various dosage forms, including capsules, tablets, granules, and pills. Its product portfolio addresses a broad range of therapeutic areas such as cardiovascular health, respiratory ailments, and digestive system disorders. The company is recognized as a high-tech enterprise in Jilin Province, integrating traditional herbal formulations with contemporary pharmaceutical manufacturing standards to serve the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Yimintang Pharmaceutical.